Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Wesseling

Showing results (11-20 of 295) with videos related to

Pageof 30
Sort By:
Brain Pathology (Zurich, Switzerland)|January 12, 2026
Reply to comments on cIMPACT-NOW update 11Pieter Wesseling, David N Louis
AJNR. American Journal of Neuroradiology|November 20, 2003
Severe tacrolimus leukoencephalopathy after liver transplantationJanneke Schuuring, Pieter Wesseling, Aad Verrips
The Journal of Pathology|October 27, 2010
MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potentialJudith W M Jeuken, Pieter Wesseling
Neuro-Oncology Practice|March 5, 2021
The cIMPACT-NOW updates and their significance to current neuro-oncology practiceL Nicolas Gonzalez Castro, Pieter Wesseling
Pathology|January 16, 2025
Pathological diagnosis of central nervous system tumours in adults: what's new?Evert-Jan Kooi, Lukas Marcelis, Pieter Wesseling
Cancer Research|June 21, 2018
Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression MonitoringMyron G Best, Pieter Wesseling, Thomas Wurdinger
Acta Neuropathologica|September 7, 2007
Diffuse glioma growth: a guerilla warAn Claes, Albert J Idema, Pieter Wesseling
Brain Pathology (Zurich, Switzerland)|September 12, 2009
Immunotherapy of diffuse gliomas: biological background, current status and future developmentsOliver M Grauer, Pieter Wesseling, Gosse J Adema
Acta Neuropathologica|May 7, 2015
Oligodendroglioma: pathology, molecular mechanisms and markersPieter Wesseling, Martin van den Bent, Arie Perry
Cornea|December 20, 2015
Unique Presentation of Corneal Opacity in Peters Plus Syndrome: An Unusual Form of Peters Anomaly Showing Tissue Repair in Serial AnalysisKarlijn F de Nie, Pieter Wesseling, Catharina A Eggink
Pageof 30

Showing results (11-20 of 295) with videos related to

Sort By:
Pageof 30
Brain Pathology (Zurich, Switzerland)|January 12, 2026
Reply to comments on cIMPACT-NOW update 11Pieter Wesseling, David N Louis
AJNR. American Journal of Neuroradiology|November 20, 2003
Severe tacrolimus leukoencephalopathy after liver transplantationJanneke Schuuring, Pieter Wesseling, Aad Verrips
The Journal of Pathology|October 27, 2010
MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potentialJudith W M Jeuken, Pieter Wesseling
Neuro-Oncology Practice|March 5, 2021
The cIMPACT-NOW updates and their significance to current neuro-oncology practiceL Nicolas Gonzalez Castro, Pieter Wesseling
Pathology|January 16, 2025
Pathological diagnosis of central nervous system tumours in adults: what's new?Evert-Jan Kooi, Lukas Marcelis, Pieter Wesseling
Cancer Research|June 21, 2018
Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression MonitoringMyron G Best, Pieter Wesseling, Thomas Wurdinger
Acta Neuropathologica|September 7, 2007
Diffuse glioma growth: a guerilla warAn Claes, Albert J Idema, Pieter Wesseling
Brain Pathology (Zurich, Switzerland)|September 12, 2009
Immunotherapy of diffuse gliomas: biological background, current status and future developmentsOliver M Grauer, Pieter Wesseling, Gosse J Adema
Acta Neuropathologica|May 7, 2015
Oligodendroglioma: pathology, molecular mechanisms and markersPieter Wesseling, Martin van den Bent, Arie Perry
Cornea|December 20, 2015
Unique Presentation of Corneal Opacity in Peters Plus Syndrome: An Unusual Form of Peters Anomaly Showing Tissue Repair in Serial AnalysisKarlijn F de Nie, Pieter Wesseling, Catharina A Eggink
Pageof 30